ASTELLAS PHARMA (Germany) Price on September 4, 2024
| YPHA Stock | EUR 9.30 0.05 0.54% |
If you're considering investing in ASTELLAS Stock, it is important to understand the factors that can impact its price. As of today, the current price of ASTELLAS PHARMA stands at 9.30, as last reported on the 23rd of November, with the highest price reaching 9.30 and the lowest price hitting 9.30 during the day. ASTELLAS PHARMA UNSPADR secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13% return per unit of risk over the last 3 months. ASTELLAS PHARMA UNSPADR exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ASTELLAS PHARMA's mean deviation of 1.3, and Risk Adjusted Performance of (0.10) to double-check the risk estimate we provide.
ASTELLAS Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
ASTELLAS |
Sharpe Ratio = -0.1323
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | YPHA |
Estimated Market Risk
| 1.61 actual daily | 14 86% of assets are more volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ASTELLAS PHARMA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ASTELLAS PHARMA by adding ASTELLAS PHARMA to a well-diversified portfolio.
ASTELLAS PHARMA Valuation on September 4, 2024
It is possible to determine the worth of ASTELLAS PHARMA on a given historical date. On September 4, 2024 ASTELLAS was worth 10.9 at the beginning of the trading date compared to the closed value of 10.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ASTELLAS PHARMA stock. Still, in general, we apply an absolute valuation method to find ASTELLAS PHARMA's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ASTELLAS PHARMA where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ASTELLAS PHARMA's related companies.
| Open | High | Low | Close | Volume | |
| 11.00 | 11.00 | 11.00 | 11.00 | 679.00 | |
09/04/2024 | 10.90 | 10.90 | 10.90 | 10.90 | 679.00 |
| 11.00 | 11.00 | 11.00 | 11.00 | 679.00 |
| Backtest ASTELLAS PHARMA | | | ASTELLAS PHARMA History | | | ASTELLAS PHARMA Valuation | Previous | Next |
ASTELLAS PHARMA Trading Date Momentum on September 4, 2024
| On September 05 2024 ASTELLAS PHARMA UNSPADR was traded for 11.00 at the closing time. The maximum traded price for the trading interval was 11.00 and the lowest daily price was 11.00 . The daily volume was recorded at 679. The volume of trading on 5th of September 2024 played a part in the next trading day price rise. The trading price change to the next closing price was 0.92% . The overall trading delta to the closing price today is 1.83% . |
ASTELLAS PHARMA UNSPADR Fundamentals Correlations and Trends
By evaluating ASTELLAS PHARMA's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ASTELLAS PHARMA's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ASTELLAS financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ASTELLAS PHARMA Stock history
ASTELLAS PHARMA investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ASTELLAS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ASTELLAS PHARMA UNSPADR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ASTELLAS PHARMA stock prices may prove useful in developing a viable investing in ASTELLAS PHARMA
Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan. ASTELLAS PHARMA operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15455 people.
ASTELLAS PHARMA Stock Technical Analysis
ASTELLAS PHARMA technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ASTELLAS PHARMA Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
ASTELLAS PHARMA UNSPADR cannot be verified against its exchange. Please verify the symbol is currently traded on Frankfurt Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ASTELLAS PHARMA November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how ASTELLAS PHARMA stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ASTELLAS PHARMA shares will generate the highest return on investment. By undertsting and applying ASTELLAS PHARMA stock market strength indicators, traders can identify ASTELLAS PHARMA UNSPADR entry and exit signals to maximize returns
ASTELLAS PHARMA Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ASTELLAS PHARMA's price direction in advance. Along with the technical and fundamental analysis of ASTELLAS Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ASTELLAS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.49) | |||
| Treynor Ratio | 1.68 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for ASTELLAS Stock analysis
When running ASTELLAS PHARMA's price analysis, check to measure ASTELLAS PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ASTELLAS PHARMA is operating at the current time. Most of ASTELLAS PHARMA's value examination focuses on studying past and present price action to predict the probability of ASTELLAS PHARMA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ASTELLAS PHARMA's price. Additionally, you may evaluate how the addition of ASTELLAS PHARMA to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |